GlassScriptPhysician profile
Jeffrey R Morin
NPI 1093701203
$12,808.66
in general payments reported to CMS, 2019-2025
17 companies · $2,374 in 2025
The $2,374 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,468 · 2020: $145 · 2021: $17.88 · 2022: $5,368 · 2023: $3,312 · 2024: $125 · 2025: $2,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,440 · Food and Beverage: $1,338 · Gift: $32.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,440.43 |
| Food and Beverage | $1,338.17 |
| Gift | $32.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $5,596.49 | 2022-2025 | |
| Arthrex, INC. | $3,159.24 | 2022-2025 | |
| Medline Industries LP | $1,679.54 | 2023 | |
| Wright Medical Technology, INC. | $968.41 | 2019-2020 | |
| Medwest Associates | $498.00 | 2019 | |
| Stryker Corporation | $485.13 | 2020-2025 | Prostep, Infinity Adaptis, Prophecy |
| Bioventus LLC | $121.17 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $65.01 | 2022-2024 | Journey II |
| Depuy Synthes Sales INC. | $49.19 | 2025 | Tfn-Advance, Na |
| Organogenesis INC. | $43.96 | 2020 | |
| Osteomed LLC | $32.46 | 2022 | |
| Treace Medical Concepts, INC. | $29.82 | 2025 | |
| Heron Therapeutics, INC. | $24.50 | 2025 | Zynrelef |
| Convatec INC. | $18.30 | 2020 | |
| Orthofix Medical, INC. | $13.77 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $11.90 | 2019 | |
| Nevro Corp. | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Morin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.